AFP and neoplasm: There are some published risk factors, including time on the waiting list, model for end-stage liver disease (MELD) score, viral etiology, serum AFP level, maximal tumor diameter, vascular invasion, pretransplantation therapy and other factors [6–8], and some of these important factors are indeed included in the expanded criteria.